Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation’s Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chronic gingivostomatitis and canine atopic dermatitis Ainos advances its product pipeline as it targets commencing clinical studies during the second quarter of 2023 SAN DIEGO, Nov. 21, 2022…

Click here to view original post